Extracts of Flavoparmelia sp. Inhibit Receptor Activator of Nuclear Factor-κB Ligand-Mediated Osteoclast Differentiation

키워드

참고문헌 (41)

1. Manolagas SC, "Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis", Endocr Rev, 21, pp.115~137 (2000)
2. Finkelstein JS, "Bone mineral density changes during the menopause transition in a multiethnic cohort of women", J Clin Endocrinol Metab, 93, pp.861~868 (2008)
3. Kanis JA, "Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds", Osteoporos Int, 12, pp.989~995 (2001)
4. Tella SH, "Prevention and treatment of postmenopausal osteoporosis", J Steroid Biochem Mol Biol, 142, pp.155~170 (2014)
5. Riggs BL, "Drugs used to treat osteoporosis: the critical need for a uniform nomenclature based on their action on bone remodeling", J Bone Miner Res, 20, pp.177~184 (2005)
6. Rodan GA, "Therapeutic approaches to bone diseases", Science, 289, pp.1508~1514 (2000)
7. Boyle WJ, "Osteoclast differentiation and activation", Nature, 423, pp.337~342 (2003)
8. Feng X, "RANKing intracellular signaling in osteoclasts", IUBMB Life, 57, pp.389~395 (2005)
9. Kansara M, "Translational biology of osteosarcoma", Nat Rev Cancer, 14, pp.722~735 (2014)
10. Takayanagi H, "Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts", Dev Cell, 3, pp.889~901 (2002)
11. Spribille T, "Basidiomycete yeasts in the cortex of ascomycete macrolichens", Science, 353, pp.488~492 (2016)
12. Kellogg JJ, "Endolichenic fungi: a new source of rich bioactive secondary metabolites on the horizon", Phytochem Rev, 16, pp.271~293 (2017)
13. Chen GD, "Xanthoquinodins from the endolichenic fungal strain Chaetomium elatum", J Nat Prod, 76, pp.702~709 (2013)
14. Li XB, "Identification and biological evaluation of secondary metabolites from the endolichenic fungus Aspergillus versicolor", Chem Biodivers, 12, pp.575~592 (2015)
15. KJ, "Decursin inhibits osteoclastogenesis by downregulating NFATc1 and blocking fusion of pre-osteoclasts", Bone, 81, pp.208~216 (2015)
16. Rozen S, "Primer3 on the WWW for general users and for biologist programmers", Methods Mol Biol, 132, pp.365~386 (2000)
17. Livak KJ, "Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method", Methods, 25, pp.402~408 (2001)
18. Kim H, "Placotylene A, an inhibitor of the receptor activator of nuclear factor-κB ligand-induced osteoclast differentiation, from a Korean sponge Placospongia sp", Mar Drugs, 12, pp.2054~2065 (2014)
19. Kim KJ, "Betulin suppresses osteoclast formation via down-regulating NFATc1", J Clin Med, 7 (2018)
20. Girlanda M, "Two foliose lichens as microfungal ecological niches", Mycologia, 89, pp.531~536 (1997)
21. Li XB, "Tetramic acids and pyridone alkaloids from the endolichenic fungus tolypocladium cylindrosporum", J Nat Prod, 78, pp.2155~2160 (2015)
22. Wu W, "Isolation and structural elucidation of proline-containing cyclopentapeptides from an endolichenic Xylaria sp", J Nat Prod, 74, pp.1303~1308 (2011)
23. Wijeratne EM, "Geopyxins A-E, ent-kaurane diterpenoids from endolichenic fungal strains Geopyxis aff. majalis and Geopyxis sp. AZ0066: structure-activity relationships of geopyxins and their analogues", J Nat Prod, 75, pp.361~369 (2012)
24. Wu YH, "Pericoterpenoid A, a new bioactive cadinane-type sesquiterpene from Periconia sp", J Asian Nat Prod Res, 17, pp.671~675 (2015)
25. Frisvad JC, "The use of secondary metabolite profiling in chemotaxonomy of filamentous fungi", Mycol Res, 112, pp.231~240 (2008)
26. Parrot D, "Comparative metabolite profiling and chemical study of Ramalina siliquosa complex using LC-ESI-MS", MS approach, 2013, pp.89, 114~124
27. Kim GS, "Bioactive α-pyrone derivatives from the endolichenic fungus dothideomycetes sp. EL003334", J Nat Prod, 81, pp.1084~1088 (2018)
28. Kim JW, "Anti-inflammatory phomalichenones from an endolichenic fungus Phoma sp", J Antibiot (Tokyo), 71, pp.753~756 (2018)
29. Kim KJ, Jeong MH, Lee Y, "Effect of usnic acid on osteoclastogenic activity", J Clin Med, 7 (2018)
30. Golob AL, "Osteoporosis: screening, prevention, and management", Med Clin North Am, 99, pp.587~606 (2015)
31. Blume SW, "Medical costs of osteoporosis in the elderly Medicare population", Osteoporos Int, 22, pp.1835~1844 (2011)
32. Svedbom A, "Osteoporosis in the European Union: a compendium of country-specific reports", Arch Osteoporos, 8, pp.137~ (2013)
33. Wade SW, "Estimating prevalence of osteoporosis: examples from industrialized countries", Arch Osteoporos, 9, pp.182~ (2014)
34. Yasuda H, "A novel molecular mechanism modulating osteoclast differentiation and function", 25, pp.109~113 (1999)
35. Sherr CJ, "Colony-stimulating factor-1 receptor", Blood, 75, pp.1~12 (1990)
36. Tanaka S, "Macrophage colony-stimulating factor is indispensable for both proliferation and differentiation of osteoclast progenitors", J Clin Invest, 91, pp.257~263 (1993)
37. Takayanagi H, "Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems", Nat Rev Immunol, 7, pp.292~304 (2007)
38. Minkin C, "Bone acid phosphatase: tartrate-resistant acid phosphatase as a marker of osteoclast function", Calcif Tissue Int, 34, pp.285~290 (1982)
39. 김봉준, "α-Tocopheryl Succinate Inhibits Osteolytic Bone Metastasis of Breast Cancer by Suppressing Migration of Cancer Cells and Receptor Activator of Nuclear Factor-κΒ Ligand Expression of Osteoblasts", 대한골대사학회지, 25(1), pp.23~33 (2018), 대한골대사학회[DOI]
40. Yagi M, "Role of DC-STAMP in cellular fusion of osteoclasts and macrophage giant cells", J Bone Miner Metab, 24, pp.355~358 (2006)
41. Matsumoto M, "Essential role of p38 mitogen-activated protein kinase in cathepsin K gene expression during osteoclastogenesis through association of NFATc1 and PU.1", J Biol Chem, 279, pp.45969~45979

관련 논문AI추천